Radiotherapy Market Research Report By Technology (External Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy, Intensity-Modulated Radiation Therapy, Stereotactic Radiosurgery), By Application (Oncology, Palliative Care, Preoperative, Postoperative, Curative Treatment), By End Use (Hospitals, Cancer Research Centers, Outpatient Facilities), By Treatment Type (Conventional Radiotherapy, Radiotherapy for Targeted Therapy, Combination Therapy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) -

Radiotherapy Market Summary

As per MRFR Analysis, the Radiotherapy Market was valued at 6.94 USD Billion in 2023 and is projected to grow to 12.5 USD Billion by 2035, driven by technological advancements and increasing cancer prevalence. The market is expected to witness a CAGR of 5.03% from 2025 to 2035, highlighting the growing demand for effective cancer treatment solutions.

Key Market Trends & Highlights

The Radiotherapy Market is evolving with significant trends that are reshaping cancer treatment.

• The market is expected to grow from 7.29 USD Billion in 2024 to 12.5 USD Billion by 2035.
• External Beam Radiotherapy is projected to increase from 2.58 USD Billion in 2024 to 4.48 USD Billion by 2035.
• The global cancer cases are anticipated to rise by about 70% over the next two decades, driving demand for radiotherapy.
• Investment in healthcare infrastructure is increasing, particularly in developing regions, enhancing access to radiotherapy services.

Market Size & Forecast

2023 Market Size: USD 6.94 Billion

2024 Market Size: USD 7.29 Billion

2035 Market Size: USD 12.5 Billion

CAGR (2025-2035): 5.03%

Largest Regional Market Share in 2024: North America.

Major Players

Key Companies include RaySearch Laboratories, ViewRay, Varian Medical Systems, OncoOne, Canon Medical Systems, GE Healthcare, and Elekta.

Key Radiotherapy Market Trends Highlighted

The Radiotherapy Market is experiencing substantial trends that are being driven by a variety of key market drivers. The increasing global incidence of cancer has become a significant factor, as more patients are pursuing advanced treatment options. The expansion of this market is further bolstered by the increased recognition of radiotherapy as an effective treatment modality.

Furthermore, the integration and advancement of cutting-edge technologies, including artificial intelligence and machine learning, into treatment planning are revolutionizing conventional methods, resulting in more precise and efficient procedures. These technological advancements not only improve patient outcomes but also simplify clinical workflows, which in turn attract increased global investments in radiotherapy infrastructure.

The Radiotherapy Market is experiencing a growth in opportunities as governments and healthcare institutions prioritize the modernization of healthcare facilities and the enhancement of cancer care. Further opportunities are presented by collaborative endeavors between the public and private sectors to improve the regulatory frameworks and develop novel therapies for innovation.

Additionally, the increasing prevalence of personalized medicine enables the development of radiotherapy treatments that are customized to the unique profiles of each patient, thereby achieving more effective outcomes. In recent years, there has been a significant shift toward the implementation of combined therapies, which involve the integration of radiotherapy, immunotherapy, and targeted therapies.

This trend underscores the importance of a more comprehensive approach to cancer treatment, which is in line with the increasing demand for treatment options that improve the quality and longevity of patient care. In general, these trends suggest that the Radiotherapy Market is characterized by a dynamic landscape, with the future of cancer treatment being influenced by continuous advancements and expanding opportunities.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Radiotherapy Market Drivers

Increasing Incidence of Cancer

The Radiotherapy Market is primarily driven by the rising incidence of cancer across the globe. According to the World Health Organization (WHO), the global cancer burden is expected to reach 29.5 million cases by the year 2040, an increase of 47% from 2020. This alarming trend highlights the growing need for cancer treatment options, including radiotherapy. Leading health organizations such as the American Cancer Society and the National Cancer Institute have reported a significant rise in various cancer types, including breast, lung, and colorectal cancers.

With approximately 1.9 million new cancer diagnoses projected in the United States alone for 2021, the pressing demand for effective treatment modalities such as radiotherapy is evident. This rising burden of cancer not only underscores the demand for advanced radiotherapy technologies but also spurs innovation and investment in the Radiotherapy Market Industry, as healthcare providers strive to enhance patient outcomes through enhanced treatment approaches.

Technological Advancements in Radiotherapy

Technological progress and innovation are key drivers propelling the Radiotherapy Market Industry forward. The introduction of advanced treatment techniques such as Stereotactic Body Radiotherapy (SBRT) and Intensity-Modulated Radiotherapy (IMRT) has transformed traditional radiotherapy into a more precise and effective weapon against cancer. The American Society for Radiation Oncology has noted a significant increase in the utilization of advanced technologies, with studies showing that IMRT can lead to improved tumor control rates and reduced side effects compared to conventional methods.

Furthermore, the growing implementation of artificial intelligence (AI) and machine learning in treatment planning processes is anticipated to enhance radiotherapy efficacy significantly. These advancements not only provide better treatment outcomes but also drive the demand for coordinating equipment and training in the Global Radiotherapy Market.

Growing Investment in Healthcare Infrastructure

The Radiotherapy Market is experiencing growth due to increased investment in healthcare infrastructure. Governments around the world, particularly in regions like Asia-Pacific and Europe, are prioritizing the enhancement of healthcare facilities and services, including cancer treatment centers. Reports indicate that healthcare expenditure in the Asia-Pacific region is expected to rise by over 30% in the next five years, leading to significant expansion in cancer care facilities.

Major organizations like the World Health Organization have underscored the necessity of strengthening healthcare systems to provide better cancer treatment access. This investment surge is likely to lead to an increase in the availability of radiotherapy services and technologies, contributing to the overall growth of the Radiotherapy Market Industry.

Rising Awareness and Early Detection Initiatives

Public awareness campaigns and early detection initiatives are fostering a favorable environment for the Radiotherapy Market Industry. Organizations such as the American Cancer Society are conducting extensive outreach programs to educate communities about the importance of cancer screening and early diagnosis. Increased awareness has been linked to earlier-stage diagnoses, which are proven to improve the success rates of radiotherapy treatments.

Statistics show that survival rates for cancers detected at an early stage are significantly higher, often exceeding 80% in several types, as found in studies published by the National Cancer Institute.

As more individuals engage in preventive health measures and screening protocols, the need for effective radiotherapy solutions will grow significantly, thereby propelling advancements and investments in the Radiotherapy Market Industry.

Radiotherapy Market Segment Insights

Radiotherapy Market Technology Insights

The Radiotherapy Market is poised for substantial growth within the Technology segment, reflecting increasing demand for innovative treatment options. By 2024, the overall market is expected to reach a valuation of 7.29 USD billion, growing further to an estimated 12.5 USD billion by 2035.

Over this period, the segment is expected to witness a compound annual growth rate (CAGR) of 5.02, driven by advancements in treatment capabilities and technology. Within this market, External Beam Radiotherapy stands out with a valuation of 2.9 USD Billion in 2024, projected to rise to 4.9 USD billion by 2035, highlighting its majority holding and significance in various cancer treatment protocols.

This method allows for precise targeting of tumors while sparing surrounding healthy tissue, marking it as a pivotal area of focus. Brachytherapy, valued at 1.5 USD Billion in 2024 and increasing to 2.5 USD billion by 2035, also holds importance for its ability to deliver localized radiation treatment, minimizing systemic exposure and enhancing patient outcomes.

Systemic Radiotherapy, although smaller, is reflective of emerging techniques with current valuations at 0.9 USD Billion for 2024 and expected to reach 1.5 USD Billion by 2035, showcasing its increasing adoption for targeting metastatic disease.

Intensity-Modulated Radiation Therapy, valued at 1.8 USD Billion in 2024 and set for growth to 3.0 USD Billion by 2035, plays a critical role in personalized cancer treatment, allowing radiation doses to conform to the three-dimensional shape of tumors, thus maximizing dose delivery and reducing side effects.

Finally, Stereotactic Radiosurgery, while the least valued at 0.19 USD Billion in 2024 and rising to 0.3 USD Billion by 2035, signifies a growing trend towards non-invasive procedures, focusing on precise and high-dose radiation in a single session, particularly advantageous for patients with limited treatment options.

The Radiotherapy Market distribution highlights that while the larger segments like External Beam Radiotherapy dominate in terms of value and application, each segment presents unique attributes that contribute to the overall landscape, driving innovation and improving clinical outcomes in cancer treatment.

These variations in technology and treatment methodologies provide healthcare professionals with a diverse toolkit, enabling tailored therapies critical for individual patient needs, thus emphasizing the growing importance of this market in the global healthcare framework.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Radiotherapy Market Application Insights

The Radiotherapy Market is expected to reach a valuation of 7.29 USD billion by 2024, showcasing the increasing significance of various applications within the healthcare sector. The Application segment includes critical areas such as Oncology, Palliative Care, Preoperative, Postoperative, and Curative Treatment, each playing a vital role in patient care.

Oncology remains a leading area due to the rising prevalence of cancer, thereby driving demand for effective treatment options. Palliative Care is gaining traction as it focuses on enhancing the quality of life for patients with serious illnesses, highlighting the need for supportive therapies.

The preoperative and postoperative applications are significant as they help prepare patients for surgery and aid recovery, improving surgical outcomes. Curative Treatment holds importance in providing definitive solutions to cancer and other diseases through radiotherapy.

The Radiotherapy Market statistics indicate that a well-rounded approach in these applications is essential for addressing diverse patient needs, contributing to the overall market growth fueled by advancements in technology and increasing healthcare funding globally.

Radiotherapy Market End Use Insights

The Radiotherapy Market is poised to achieve a valuation of 7.29 USD billion by 2024, reflecting the increasing significance of radiotherapy in cancer treatment. The End Use segment is primarily composed of hospitals, cancer research centers, and outpatient facilities, each playing a crucial role in delivering effective radiotherapy solutions.

Hospitals serve the majority of patients and are at the forefront of implementing advanced radiotherapy technologies, elevating treatment success rates significantly. Cancer research centers are integral to the Radiotherapy Market as they innovate and conduct clinical trials, contributing to the development of cutting-edge therapeutic techniques.

Outpatient facilities cater to a growing segment of patients seeking convenient and efficient treatment options, which is especially vital as healthcare models evolve towards ambulatory care. The Radiotherapy Market statistics demonstrate a robust market growth driven by increasing cancer prevalence and technological advancements in treatment devices.

Factors such as enhanced awareness, improved healthcare infrastructure, and supportive government initiatives are further propelling this market forward. At the same time, challenges like high treatment costs and regulatory hurdles continue to linger, creating both obstacles and opportunities within this evolving landscape.

Radiotherapy Market Treatment Type Insights

The Radiotherapy Market is experiencing significant growth, with a valuation of USD 7.29 billion expected by 2024 and a projection of USD 12.5 billion by 2035. This market is categorized by Treatment Type, which includes Conventional Radiotherapy, Radiotherapy for Targeted Therapy, and Combination Therapy.

Conventional Radiotherapy continues to represent a major preference due to its established protocols and widespread use in clinical settings, providing effective treatment options for various cancer types. Radiotherapy for Targeted Therapy is gaining traction as it offers a more personalized approach by specifically targeting cancer cells, thus minimizing damage to surrounding healthy tissue.

Combination Therapy, which integrates radiotherapy with other treatment modalities, is increasingly recognized for enhancing treatment efficacy and improving patient outcomes. The consistent innovation and advancements in technology are driving growth in these areas, addressing the need for more effective cancer treatments worldwide.

Moreover, the increasing prevalence of cancer, coupled with rising investments in healthcare infrastructure, provides ample opportunities for expansion and further development in the Global Radiotherapy Market.

Radiotherapy Market Regional Insights

The Radiotherapy Market is experiencing significant growth, with an overall market valuation of 7.29 USD billion anticipated in 2024 and expected to rise to 12.5 USD billion by 2035. Within the regional landscape, North America holds a majority share, valued at 3.0 USD billion in 2024 and anticipated to reach 5.2 USD billion by 2035, driven by advanced healthcare infrastructure and increasing cancer incidences. Europe follows, valued at 2.5 USD Billion in 2024, reflecting a robust healthcare framework and focus on Research and Development in cancer treatment technology, projected to grow to 4.3 USD billion by 2035.

The Asia Pacific region demonstrates a promising market, valued at 1.8 USD billion in 2024, benefiting from rising healthcare investments and populations needing radiation treatment, forecasted to expand to 2.9 USD billion by 2035. South America and the Middle East, and Africa represent smaller segments, valued at 0.6 USD Billion and 0.39 USD Billion in 2024, respectively, but show potential for growth due to improving healthcare systems and increased awareness about cancer treatment options, expected to reach 1.0 USD Billion and 0.7 USD Billion by 2035.

This diverse regional segmentation highlights unique market dynamics and opportunities tied to varying healthcare developments and population health challenges worldwide.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Radiotherapy Market Key Players and Competitive Insights

The Radiotherapy Market is characterized by a dynamic and competitive landscape where various companies are striving to establish their dominance through advanced technological innovations and strategic partnerships. With the increasing prevalence of cancer globally, the demand for effective radiotherapy solutions has surged, prompting healthcare providers to adopt state-of-the-art services.

This has led to a proliferation of companies offering various radiation treatment modalities, including external beam radiation therapy and brachytherapy, which are tailored to improve patient outcomes.

The competitive insights highlight not only the market share held by different entities but also the unique value propositions they bring to the table, including their research capabilities, product diversification, and customer-centric approaches that cater to diverse patient needs. By recognizing these competitive forces, stakeholders can better navigate this complex market.

Radiation Therapy Services, a prominent player within the Global Radiotherapy Market, boasts a strong presence in the realm of radiation oncology. The company leverages its extensive network of specialized treatment centers that focus on providing cutting-edge radiation therapy solutions. One of the core strengths of Radiation Therapy Services is its commitment to continuous innovation and quality improvement, ensuring that it remains at the forefront of technological advancements.

The organization excels in delivering personalized therapy plans that are tailored to meet the unique requirements of patients, ultimately enhancing treatment efficacy. Additionally, its strategic collaborations with hospitals and healthcare providers amplify its market presence, allowing for a more comprehensive service offering that caters to a wide demographic.

Accuray, a key entity in the Global Radiotherapy Market, is renowned for its advanced treatment systems, notably the CyberKnife and TomoTherapy platforms, which revolutionize patient care in radiation therapy. Accuray's focus on precision and adaptability in treatment planning positions it favorably in an increasingly competitive landscape. The company emphasizes its strong market presence through strategic partnerships and initiatives aimed at enhancing accessibility to its innovative technologies.

One of the notable strengths of Accuray lies in its ongoing commitment to research and development, leading to significant advancements in treatment accuracy and patient safety. Moreover, its active pursuit of mergers and acquisitions has enabled it to expand its product offerings and geographical reach, solidifying its standing as a pioneer in the field of radiotherapy. This relentless drive for innovation, combined with its focused strategy, enhances Accuray's capabilities to address the evolving challenges within the Global Radiotherapy Market.

Key Companies in the Radiotherapy Market Include

• Radiation Therapy Services


• Accuray


• Siemens Healthineers


• Elekta


• Canon Medical Systems


• Varian Medical Systems


• Mevion Medical Systems


• Toshiba Medical Systems


• Ion Beam Applications

Radiotherapy Market Industry Developments

Recent developments in the Radiotherapy Market reflect a dynamic landscape where technological advancements and strategic collaborations are reshaping the industry. Companies such as Varian Medical Systems and Accuray are at the forefront, emphasizing the integration of artificial intelligence in treatment planning to enhance precision and outcomes.

In June 2025, Cama & Albless Hospital in Mumbai, India, reopened its free targeted radiotherapy trials for patients and reduced the demand on other major cancer centers by installing a new linear accelerator after a two-year hiatus.

In May 2025, Varian (Siemens Healthineers) and Siemens Healthineers present AI-driven MRI-based radiotherapy technology at ESTRO 2025 in Vienna. This technology includes RapidArc Dynamic, ARIA CORE Automations, and deep-learning MRI auto-contouring.

 In May 2025, Siemens Healthineers announced a $150 million U.S. investment to relocate Varian manufacturing from Mexico to California, expand supply hubs (Dayton, NJ; Manteca, CA), and establish a new Experience Center in Charlotte, NC.

Radiotherapy Market Segmentation Insights

Radiotherapy Market Technology Outlook

• External Beam Radiotherapy


• Brachytherapy


• Systemic Radiotherapy


• Intensity-Modulated Radiation Therapy


• Stereotactic Radiosurgery

Radiotherapy Market Application Outlook

• Oncology


• Palliative Care


• Preoperative


• Postoperative


• Curative Treatment

Radiotherapy Market End Use Outlook

• Hospitals


• Cancer Research Centers


• Outpatient Facilities

Radiotherapy Market Treatment Type Outlook

• Conventional Radiotherapy


• Radiotherapy for Targeted Therapy


• Combination Therapy

Radiotherapy Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric	Details
Market Size 2023	6.94(USD Billion)
Market Size 2024	7.29(USD Billion)
Market Size 2035	12.5(USD Billion)
Compound Annual Growth Rate (CAGR)	5.02% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Radiation Therapy Services, Accuray, Siemens Healthineers, Elekta, GE Healthcare, Phillips Healthcare, ViewRay, Canon Medical Systems, Varian Medical Systems, Mevion Medical Systems, Toshiba Medical Systems, Ion Beam Applications
Segments Covered	Technology, Application, End Use, Treatment Type, Regional
Key Market Opportunities	Increased cancer prevalence, Advancements in technology, Expansion in emerging markets, Growing demand for proton therapy, Rise in personalized medicine approaches
Key Market Dynamics	Increasing cancer prevalence, Advancements in technology, Rising healthcare expenditure, Growing geriatric population, Strong demand for precision medicine
Countries Covered	North America, Europe, APAC, South America, MEA